CRISPR-edited insulin cells restore natural insulin in a Type 1 diabetes patient without rejection or immunosuppressants, ...
"My fascination with this topic started when I was taking care of a patient who had undergone bariatric surgery with type 2 ...
GlobalData on MSN
Silver Creek’s stroke hopeful yields mixed results in Phase II trial
If approved, the targeted IGF-1 fusion protein would become the only treatment available for late-window stroke patients ...
More than 160 Florida medical marijuana patients arrested for drug convictions either have lost or are in jeopardy of losing ...
This shift could improve care coordination and create opportunities for cost savings through enhanced formulary flexibility ...
Heart disease claims nearly 18 million lives annually, but renowned cardiologist Dr. Pradip Jamnadas says its roots lie in ...
Wellbeing Whisper on MSN
ACA Subsidy Expiration Could Double Premiums, Leaving Millions in Limbo
What happens when a lifeline is cut in half? For millions of Americans who depend on Affordable Care Act (ACA) enhanced ...
Biotech clinical laboratories are at the center of new medical discoveries, using tools like molecular biology and genetics ...
California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results